Invivyd, Inc. (IVVD)
NASDAQ: IVVD · Real-Time Price · USD
0.5933
-0.0166 (-2.72%)
At close: Jul 28, 2026, 4:00 PM EDT
0.5986
+0.0053 (0.89%)
Pre-market: Jul 29, 2026, 5:09 AM EDT

Revenue by Segment

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Discovery, Development and Commercialization of Antibody-Based Solutions
53.43M25.38M---
Total
53.43M25.38M---

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
United States
53.43M25.38M---
Total
53.43M25.38M---